Dr. Gayatri Gogoi Research Projects
Welcome to Dr. Gayatri Gogoi Research Work, dedicated to enhancing knowledge and insights in breast cancer research. Our mission is to disseminate innovative research discoveries, showcase key publications, and offer a detailed overview of our initiatives. Here, you can explore Dr. Gogoi's journey, her significant contributions to the field, and the of her research on both patients and the medical community. We strive to promote collaboration and communication among researchers, healthcare professionals, and patients.
Research Project
Ongoing Research Projects :
As Principal Investigator
Sl. No. 1 :
Name of the project : Development & Clinical validation of a Multimodal Intraoperative Probe for Breast Cancer Margin Assessment.
Funding Agency : Indian Council of Medical Research (ICMR)
Sl. No. 2 :
Name of the project : Starting of Molecular Pathology testing in a Tertiary Care Centre of Northeast India for detection of diagnostically and prognostically significant mutations in Haematolymphoid malignancies.
Funding Agency : Pratishruti Cancer & Palliative Trust, Dibrugarh
Sl. No. 3 :
Name of the project : To Study Androgen Receptor Mediated events and molecular heterogeneity in Breast Cancer.
Funding Agency : AIIMS, New Delhi
Sl. No. 4 :
Name of the project : Post-vaccination Immune Status Surveillance of HPV Vaccine “Cervavac” among vaccine beneficiaries of age group 18 to 26 years in Assam and compare the antibody titres in between 2nd and 3rd dose.
Funding Agency : ICMR-NIHR, Dibrugarh
Sl. No. 5 :
Name of the project : To compare immunophenotype–karyotype and molecular profile of BCR-ABL1 transcript positive Acute Lymphoblastic Leukaemia (ALL) with BCR-ABL1 negative ALL profile and follow up for survival outcome of both categories: a study from Upper Assam
Funding Agency : MRU-DHR, Govt. of India
Sl. No. 6 :
Name of the project : Genomic profiling of on target-mutation in first-generation Tyrosine Kinase Inhibitor (TKI) treatment resistant Chronic Myeloid Leukemia (CML) cases for better management: a study from Assam.
Funding Agency : ICMR-NIHR, Dibrugarh
Sl. No. 7 :
Name of the project : Correlation of dual-probe HER2 FISH patterns as per ASCO/CAP guidelines and HER2 gene expression by Quantitative PCR with IHC scores 2+ and 3+ in invasive breast carcinoma.
Funding Agency : MRU-DHR, Govt. of India
As Co Principal Investigator
Sl. No. 1 :
Name of the project : To explore the efficacy of Poly Adenosine diphosphate-Ribose Polymerase- Inhibitor (PARPPi) on the tumour stemness and c-Master Regulator of Cell Cycle Entry and Proliferative Metabolism (c-MYC) status in Triple Negative Breast Cancer (TNBC)
Funding Agency : Indian Council of Medical Research
Sl. No. 2 :
Name of the project : Proteomics, genomics and biochemical analysis for identification of novel biomarker for predicting PIH in HDSS panel from Dibrugarh
Funding Agency : Indian Council of Medical Research
Research Projects Completed:
As Principal Investigator
Sl. No. 1 :
Name of the project : Development and Clinical Validation of a Electro-Thermo-Mechanical Phenotyping based Cancer Prognostic Tool for better disease management of breast cancer.
Funding Agency : Anusandhan National Research Foundation, ANRF (formerly Science and Engineering Research Board, SERB) Govt. of India.
Sl. No. 2 :
Name of the project : A case control pilot study for identification and validation of Gall bladder cancer biomarkers from North East Indian Population an using transcriptomics approach.
Funding Agency : Tezpur University (Central).
Sl. No. 3 :
Name of the project : A Comparative evaluation of Physicochemical and biochemical factors associated with Gallstone disease and Gallbladder cancer in North East India.
Funding Agency : Tezpur University (Central).
Sl. No. 4 :
Name of the project : Evaluation of ER, PR, Her2 and Ki67 in invasive breast carcinoma and correlate with clinicopathological parameters in a tertiary care Hospital.
Funding Agency : Srimanta Sankardev University and Health Sciences.
Sl. No. 5 :
Name of the project : Study of Breast Cancer subtypes based on Estrogen Receptor, progesterone Receptor, Her2neu expression with special emphasis on triple negatives by immunohistochemistry.
Funding Agency : Indian Council of Medical Research (ICMR) Seed Grant.
Sl. No. 6 :
Name of the project : Study of suspected SARS COV2 reinfection in health care workers of AMCH.
Funding Agency : MRU-DHR, Govt. of India.
Sl. No. 7 :
Name of the project : Study on COVID 19 positive Health Care workers of Assam Medical College and Hospital to understand the clinical and laboratory behavior of SARS COV2 and detection of antibodies.
Funding Agency : MRU-DHR, Govt. of India.
Sl. No. 8 :
Name of the project : Post Vaccine Immune Status Surveillance of Covishield (ChAdOxl nCov 19 recombinant) vaccine and associated AEFI in previously SARS-Cov2 infected seropositive and naïve seronegative population in Northeast India.
Funding Agency : MRU-DHR, Govt. of India.
As Co Principal Investigator
Sl. No. 1 :
Name of the project : Germline mutation spectra of BRCA1 and BRCA2 genes in multi-ethnic breast cancer patients from NE region based on direct sequencing.
Funding Agency : Indian Council of Medical Research.
Sl. No. 2 :
Name of the project : BMP Signaling in Osteolytic Bone Metastasis of Breast Cancer.
Funding Agency : Indian Council of Medical Research (ICMR) Seed Grant for NE India.
Sl. No. 3 :
Name of the project : Sub-typing of Non Hodgkins lymphoma and risk factor determination in a population of North East India: A Hospital based Case-Control Study.
Funding Agency : Indian Council of Medical Research (ICMR) Seed Grant.
Sl. No. 4 :
Name of the project : Prevalence of HPV by Molecular Detection among Volunteers of Cervical Cancer Screening by PAP Smear Cytology Attending O and G.
Funding Agency : MRU-DHR, Govt. of India.
Sl. No. 5 :
Name of the project : Study on persistence of high-risk HPV infection and its association with specific epigenetic markers and HLA-class-II gene polymorphism among adult females from Northeast India.
Funding Agency : Indian Council of Medical Research.
